Literature DB >> 11815352

Systemic vascular endothelial cell dysfunction in normal pressure glaucoma.

Christine Buckley1, Patrick W F Hadoke, Emer Henry, Colm O'Brien.   

Abstract

AIM: Vascular risk factors, and particularly vasospasm, are thought to play a part in the pathogenesis of normal pressure glaucoma (NPG). This study aimed to determine whether the function of systemic resistance arteries was altered in patients with NPG.
METHODS: Contractile and relaxant function was assessed in arteries dissected from gluteal fat biopsies (11 NPG, 12 control) using small vessel myography.
RESULTS: Responses to K(+) and noradrenaline were similar in patients and controls and were unaffected by endothelial removal. In contrast, responses to 5-hydroxytryptamine (5-HT; pD(2); 7.29 (SD 0.16) v 6.66 (0.19); p=0.03) and endothelin-1 (ET-1; pD(2), 9.12 (0.10) v 8.72 (0.13); p=0.03) were enhanced in arteries from patients with NPG. Removal of the endothelium enhanced responses to 5-HT (pD(2), 6.66 (0.19) v. 7.66 (0.08); p=0.003) and ET-1 (pD(2), 8.72 (0.13) v. 9.66 (0.39); p=0.02) in control arteries but not in those from patients. ET-1 mediated contraction in control and patient arteries was reduced in the presence of (10(-5) M) nifedipine. Endothelium dependent and independent relaxation was not impaired in arteries from patients.
CONCLUSIONS: This study has identified dysfunction of the systemic vascular endothelial cell in patients with normal pressure glaucoma. The vascular endothelium modulates contractile responses to 5-HT and ET-1 in human subcutaneous resistance arteries but this effect is lost in patients with NPG, indicating a selective defect in agonist mediated release of endothelium derived vasodilators. Selective antagonists of 5-HT and ET-1 may, therefore, help to prevent vasospasm in patients with NPG.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815352      PMCID: PMC1770997          DOI: 10.1136/bjo.86.2.227

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  31 in total

1.  Response of blood flow to warm and cold in normal and low-tension glaucoma patients.

Authors:  S M Drance; G R Douglas; K Wijsman; M Schulzer; R J Britton
Journal:  Am J Ophthalmol       Date:  1988-01-15       Impact factor: 5.258

2.  Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man.

Authors:  P Vallance; J Collier; S Moncada
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

3.  Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery.

Authors:  D S Houston; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

4.  Peripheral endothelial dysfunction in normal pressure glaucoma.

Authors:  E Henry; D E Newby; D J Webb; C O'Brien
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-07       Impact factor: 4.799

5.  Endothelial alpha 2-adrenoceptors in canine pulmonary and systemic blood vessels.

Authors:  V M Miller; P M Vanhoutte
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

6.  The effect of Ca2(+) -antagonist on visual field in low-tension glaucoma.

Authors:  Y Kitazawa; H Shirai; F J Go
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

7.  Migraine and low-tension glaucoma. A case-control study.

Authors:  C D Phelps; J J Corbett
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-08       Impact factor: 4.799

8.  Systemic factors in patients with low-tension glaucoma.

Authors:  I Goldberg; F C Hollows; M A Kass; B Becker
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

9.  Optic disc hemorrhage in low-tension glaucoma.

Authors:  Y Kitazawa; S Shirato; T Yamamoto
Journal:  Ophthalmology       Date:  1986-06       Impact factor: 12.079

Review 10.  Disc hemorrhages in the glaucomas.

Authors:  S M Drance
Journal:  Surv Ophthalmol       Date:  1989 Mar-Apr       Impact factor: 6.048

View more
  29 in total

1.  Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma.

Authors:  M Emre; S Orgül; T Haufschild; S G Shaw; J Flammer
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

Review 2.  Focus on molecular events in the anterior chamber leading to glaucoma.

Authors:  Sergio Claudio Saccà; Alberto Izzotti
Journal:  Cell Mol Life Sci       Date:  2013-10-19       Impact factor: 9.261

Review 3.  [Functional disorders in the chronological progression of glaucoma].

Authors:  Carl Erb
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

Review 4.  Endothelial dysfunction in cardiovascular disease and Flammer syndrome-similarities and differences.

Authors:  Jens Barthelmes; Matthias P Nägele; Valeria Ludovici; Frank Ruschitzka; Isabella Sudano; Andreas J Flammer
Journal:  EPMA J       Date:  2017-06-06       Impact factor: 6.543

5.  Enhanced endothelium derived hyperpolarising factor activity in resistance arteries from normal pressure glaucoma patients: implications for vascular function in the eye.

Authors:  C Cleary; C H Buckley; E Henry; P McLoughlin; C O'Brien; P W F Hadoke
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

6.  Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Francesco Semeraro; Adolfo Sebastiani
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

Review 7.  Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis.

Authors:  H E Killer; A Pircher
Journal:  Eye (Lond)       Date:  2018-02-19       Impact factor: 3.775

8.  Nailfold Capillary Abnormalities in Primary Open-Angle Glaucoma: A Multisite Study.

Authors:  Louis R Pasquale; Akiko Hanyuda; Ai Ren; Michael Giovingo; Scott H Greenstein; Clara Cousins; Thomas Patrianakos; Angelo P Tanna; Christopher Wanderling; William Norkett; Janey L Wiggs; Kelsey Green; Jae H Kang; Paul A Knepper
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

9.  Microvascular endothelial function and primary open angle glaucoma.

Authors:  Syed Mudassar Imran Bukhari; Kiu Kwong Yew; Rajasunthari Thambiraja; Sarina Sulong; Aida Hanum Ghulam Rasool; Liza-Sharmini Ahmad Tajudin
Journal:  Ther Adv Ophthalmol       Date:  2019-08-22

10.  Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control.

Authors:  Yolandi van der Merwe; Matthew C Murphy; Jeffrey R Sims; Muneeb A Faiq; Xiao-Ling Yang; Leon C Ho; Ian P Conner; Yu Yu; Christopher K Leung; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.